← Evidence map

ArticleInternational cancer conference journal2022

A case of recurrent refractory cervical primary histiocytic sarcoma treated with pembrolizumab.

Yu Furui et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

6 papers cite it

2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 36186222